NCT01330979View on ClinicalTrials.gov

24-hour Efficacy of AR-12286

PHASE2CompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

May 31, 2011

Primary Completion Date

August 31, 2012

Study Completion Date

August 31, 2012

Conditions
Open Angle GlaucomaOcular Hypertension
Interventions
DRUG

AR-12286 0.5% Ophthalmic Solution

Ophthalmic Solution

Trial Locations (1)

92093

University of California, San Diego

Sponsors
All Listed Sponsors
lead

Aerie Pharmaceuticals

INDUSTRY

NCT01330979 - 24-hour Efficacy of AR-12286 | Biotech Hunter | Biotech Hunter